#eli-lilly

[ follow ]
#weight-loss #pharmaceuticals #glp-1 #orforglipron #obesity-treatment #novo-nordisk #mounjaro #stock-market
US politics
fromwww.independent.co.uk
1 week ago

Mounjaro manufacturer blasts UK as worst country in Europe' for drug prices

Eli Lilly warns that the UK's low drug prices may deter new medicines and investment, criticizing pricing under the VPAG and citing recent industry pullbacks.
Medicine
fromwww.theguardian.com
2 weeks ago

Novo Nordisk shares shoot up amid promising results for anti-obesity pill

Novo Nordisk’s once-daily oral GLP-1 pill produced weight loss nearly matching its Wegovy injection and boosted market value amid competition with Eli Lilly.
Business
from24/7 Wall St.
2 weeks ago

3 Stocks Insiders Are Buying Non-Stop

Company insiders are aggressively buying their own stock in 2025, notably at Eli Lilly and Matador Resources, signaling confidence amid recent stock declines.
#orforglipron
Wearables
fromwww.nytimes.com
5 months ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromBusiness Insider
5 months ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
Wearables
fromNew York Post
5 months ago

Everything to know about the new weight loss pill that works as well as Ozempic - and when you can get it

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.
Wearables
fromwww.nytimes.com
5 months ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromBusiness Insider
5 months ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
more#orforglipron
#stock-performance
more#stock-performance
#mounjaro
more#mounjaro
#weight-loss
more#weight-loss
from24/7 Wall St.
1 month ago

Eli Lilly Ranks Among Top Large-Cap Performers as GLP-1 Drug Sales Exceed Billions

Eli Lilly (NYSE:LLY) has quickly emerged as one of Wall Street's biggest winners, fueled by explosive demand for its new generation of weight-loss and diabetes treatments. The company's GLP-1 drugs, including Mounjaro and the newly approved Zepbound, have turned into blockbuster products, generating billions in sales and reshaping the pharmaceutical landscape. As a result, Eli Lilly's stock surged more than 50% year-to-date in 2024.
Healthcare
Photography
fromFast Company
1 month ago

Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines

Eli Lilly has signed a $1.3 billion deal with Superluminal Medicines to develop AI-driven drugs targeting obesity and cardiometabolic diseases.
Miscellaneous
fromBusiness Insider
2 months ago

Eli Lilly's 3-step strategy to dominate the $95 billion obesity market

Eli Lilly is becoming the leader in weight loss drugs, surpassing competitors like Novo Nordisk. Their drug portfolio is innovative and expansive.
fromFast Company
3 months ago

Eli Lilly is making it cheaper and easier to buy high-doses of blockbuster weight-loss drug Zepbound

"Obesity is a serious, chronic disease, and access to obesity medications should be treated with the same urgency as other chronic conditions," said Rhonda Pacheco, emphasizing the importance of medication access.
Wearables
#pharmaceuticals
more#pharmaceuticals
Startup companies
from24/7 Wall St.
3 months ago

Visa, Eli Lilly or Netflix- Which Stock Will Be A Trillion Dollar Company Next?

Visa, Netflix, and Eli Lilly are contenders for the trillion-dollar club, each poised for significant market growth.
Intellectual property law
fromAbove the Law
4 months ago

Patenting Privation (Part III): Empowering Revenge - Above the Law

The FDA's lifting of the shortage declaration has curtailed bulk sales of competing diabetes medications, impacting telehealth revenues significantly.
#novo-nordisk
more#novo-nordisk
London startup
from24/7 Wall St.
5 months ago

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly aims to become the first healthcare company with a $1 trillion market cap, spurred by its GLP-1 therapy leadership.
Orforglipron's success in trials positions Lilly for significant market growth in obesity and diabetes management.
fromwww.npr.org
5 months ago

Eli Lilly sues companies selling alternative versions of its weight loss drug

Eli Lilly is suing four telehealth companies for selling illegal copies of its weight-loss drug Zepbound, which is based on the active ingredient tirzepatide.
Alternative medicine
Cryptocurrency
from24/7 Wall St.
5 months ago

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

Market reactions are mixed due to President Trump's comments about the Federal Reserve, impacting the Dow Jones and S&P 500 differently.
Eli Lilly's new diabetes drug shows promising results, significantly boosting its stock value.
Wearables
fromNew York Post
5 months ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

Eli Lilly's orforglipron shows significant weight loss for Type 2 diabetes patients, potentially rivaling injectable medications.
Lilly's shares surged 15% following promising clinical trial results for orforglipron.
from24/7 Wall St.
5 months ago

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

That's where being a savvy investor comes in. Being contrarian, you can pick up these hidden gems at a significant discount and profit all the way to the bank when their fortunes turn.
Startup companies
[ Load more ]